Literature DB >> 7962263

Typing of hepatitis C virus isolates by DNA enzyme immunoassay.

S Viazov1, A Zibert, K Ramakrishnan, A Widell, A Cavicchini, E Schreier, M Roggendorf.   

Abstract

Recently, at least six types of hepatitis C viruses (HCV) have been identified. Different types of HCV appear to possess different pathogenic properties and a different sensitivity to interferon treatment. Typing of HCV isolates may therefore be an important diagnostic procedure. We report on a new method for identification of HCV types 1a, 1b, 2a, 2b and 3a which are most prevalent in Europe, North America and Japan. The assay is based on a combination of two well established techniques, the polymerase chain reaction (PCR) and DNA enzyme immunoassay (DEIA). In the first step of the method a cDNA of about 250 bp corresponding to the HCV core-region is amplified by nested PCR. The target cDNA is then hybridized to type-specific oligonucleotides fixed to a solid phase through an avidin-biotin bridge. The formed hybrids are detected by a standard ELISA using monoclonal antibodies reacting with double-stranded DNA. Typically, signal-to-noise (S/N) ratios between 18.2 and 48.6 could be observed when different HCV types/subtypes were analyzed by this method. The test was evaluated using cloned HCV cDNAs of known types and by sequence determination of some of the typed cDNAs. Typing of 115 isolates from Germany, Russia and Turkey revealed that subtype 1b (59-100%) and 1a (24-32%) are most prevalent in these countries.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7962263     DOI: 10.1016/0166-0934(94)90091-4

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  23 in total

1.  Development and evaluation of a DNA enzyme immunoassay method for env genotyping of subtypes A through G of human immunodeficiency virus type 1 group M, with discrimination of the circulating recombinant forms CRF01_AE and CRF02_AG.

Authors:  Jean-Christophe Plantier; Laurence Vergne; Florence Damond; Souleymane MBoup; Eitel MPoudi-NGole; Laurence Buzelay; Isabelle Farfara; Denys Brand; Martine Peeters; Françoise Brun-Vézinet; Eric Delaporte; Francis Barin
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

2.  HCV transmission in family members of subjects with HCV related chronic liver disease.

Authors:  L Demelia; E Vallebona; R Poma; G Sanna; G Masia; R C Coppola
Journal:  Eur J Epidemiol       Date:  1996-02       Impact factor: 8.082

Review 3.  Molecular typing of enteroviruses: current status and future requirements. The European Union Concerted Action on Virus Meningitis and Encephalitis.

Authors:  P Muir; U Kämmerer; K Korn; M N Mulders; T Pöyry; B Weissbrich; R Kandolf; G M Cleator; A M van Loon
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

4.  Mistyping of two Slovenian hepatitis C virus subtype 2c isolates as subtype 2b by two 5' noncoding region genotyping methods.

Authors:  K Seme; M Poljak; S Koren; P Dovc
Journal:  J Clin Microbiol       Date:  1997-12       Impact factor: 5.948

Review 5.  Hepatitis C virus: molecular biology and genetic variability.

Authors:  C Bréchot
Journal:  Dig Dis Sci       Date:  1996-12       Impact factor: 3.199

6.  Quantitation of HCV viraemia by branched DNA signal amplification in patients treated with alpha-interferon--a longitudinal study.

Authors:  R Iuliano; A M Pizzigallo; A Alecci; L Barsanti; R Trovato; G Forastieri; S Lico; C Palmieri; M Brizzi; N Marino; L Mecocci; F Mazzotta; L Ceccherini-Nelli
Journal:  Infection       Date:  1996 Jul-Aug       Impact factor: 3.553

7.  High prevalence of HCV-RNA in the saliva cell fraction of patients with chronic hepatitis C but no evidence of HCV transmission among sexual partners.

Authors:  P Fabris; D Infantolino; M R Biasin; G Marchelle; E Venza; V Terribile Wiel Marin; P Benedetti; G Tositti; V Manfrin; F de Lalla
Journal:  Infection       Date:  1999 Mar-Apr       Impact factor: 3.553

8.  Prevalence of hepatitis C virus and distribution of its genotypes in Northern Eurasia.

Authors:  D K Lvov; E I Samokhvalov; F Tsuda; N A Selivanov; H Okamoto; V M Stakhanova; I V Stakhgildyan; N V Doroshenko; T L Yashina; S N Kuzin; I A Suetina; P G Deryabin; L A Ruzaeva; V N Bezgodov; L A Firsova; S N Sorinson; S Mishiro
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

9.  HGV/GBV-C in liver tissue and in sera from patients with chronic hepatitis C.

Authors:  P Fabris; M R Biasin; D Infantolino; L Romanó; P Benedetti; G Tositti; G P Pellizzer; A R Zanetti; C Stecca; G Marchelle; F de Lalla
Journal:  Infection       Date:  1998 Sep-Oct       Impact factor: 3.553

10.  Hepatitis C virus genotype frequency in Isfahan province of Iran: a descriptive cross-sectional study.

Authors:  Sayyed H Zarkesh-Esfahani; Mohammad T Kardi; Masoud Edalati
Journal:  Virol J       Date:  2010-03-24       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.